Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PhRMA names general counsel

Executive Summary

Conan Grames will join the Pharmaceutical Research & Manufacturers of America as VP and general counsel on Feb. 6. Grames is replacing Bruce Kuhlik, who left PhRMA in May for Merck (1"The Pink Sheet" May 2, 2005, In Brief). Diane Bieri, who has been serving as acting general counsel, is now chief deputy general counsel. Grames has been chairman of the International Law Practice Section of Kirton & McConkie in Salt Lake City, Utah, where he was responsible for developing the Health Services Group at the firm. Prior to joining Kirton & McConkie, Grames served as VP-international policy and compliance at Bristol-Myers Squibb, where he spent 17 years in various senior positions in the legal division of the company...

Conan Grames will join the Pharmaceutical Research & Manufacturers of America as VP and general counsel on Feb. 6. Grames is replacing Bruce Kuhlik, who left PhRMA in May for Merck (1 'The Pink Sheet' May 2, 2005, In Brief). Diane Bieri, who has been serving as acting general counsel, is now chief deputy general counsel. Grames has been chairman of the International Law Practice Section of Kirton & McConkie in Salt Lake City, Utah, where he was responsible for developing the Health Services Group at the firm. Prior to joining Kirton & McConkie, Grames served as VP-international policy and compliance at Bristol-Myers Squibb, where he spent 17 years in various senior positions in the legal division of the company....

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046814

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel